2017, Number S2
<< Back Next >>
Rev Mex Anest 2017; 40 (S2)
Physiology of haemostasis
Grimaldo-Gómez FA
Language: Spanish
References: 8
Page: 398-400
PDF size: 160.80 Kb.
Text Extraction
No abstract
REFERENCES
Cesarman-Maus G, Meillón L, Volkow P, Vargas-Ruiz AG, Cornejo P, López-Navarro O, et al. Treatment of cancer and thrombosis: practical approach. Rev Invest Clin. 2013;65:174-182.
Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol. 2014;34:2363-2371.
Orsini S, Noris P, Bury L, Heller PG, Santoro C, Kadir RA, et al. Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study. Haematologica. 2017. pii: haematol.2016.160754.
Soviero F, Geraci A, Termine S, Sanfilippo A, Maritano RM, D’Arienzo M, et al. Bleeding in orthopaedic surgery: the role of blood transfusion and erythropoietin alpha. Acta Biomed. 2010;81:125-129.
Huntington JA. Thrombin plasticity. Biochim Biophys Acta. 2012;1824:246-252.
Hur WS, Mazinani N, Lu XJ, Britton HM, Byrnes JR, Wolberg AS, et al. Coagulation factor XIIIa is inactivated by plasmin. Blood. 2015;126:2329-2337.
Ünlü B, Bogdanov VY, Versteeg HH. Interplay between alternatively spliced Tissue Factor and full length Tissue Factor in modulating coagulant activity of endothelial cells. Thromb Res. 2017;156:1-7.
Lwaleed BA, Bass PS. Tissue factor pathway inhibitor: structure, biology and involvement in disease. J Pathol. 2006;208:327-339.
Full text